PE79899A1 - Derivados de la 9-oxima eritromicina - Google Patents

Derivados de la 9-oxima eritromicina

Info

Publication number
PE79899A1
PE79899A1 PE1998000470A PE00047098A PE79899A1 PE 79899 A1 PE79899 A1 PE 79899A1 PE 1998000470 A PE1998000470 A PE 1998000470A PE 00047098 A PE00047098 A PE 00047098A PE 79899 A1 PE79899 A1 PE 79899A1
Authority
PE
Peru
Prior art keywords
alkyl
replaced
alcanoyl
cr7r8
optionally replaced
Prior art date
Application number
PE1998000470A
Other languages
English (en)
Spanish (es)
Inventor
Yong-Jin Wu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE79899A1 publication Critical patent/PE79899A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PE1998000470A 1997-06-11 1998-06-08 Derivados de la 9-oxima eritromicina PE79899A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
PE79899A1 true PE79899A1 (es) 1999-08-25

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000470A PE79899A1 (es) 1997-06-11 1998-06-08 Derivados de la 9-oxima eritromicina

Country Status (31)

Country Link
EP (1) EP0988308A1 (cs)
JP (1) JP2000513026A (cs)
KR (1) KR20010013660A (cs)
CN (1) CN1259135A (cs)
AP (1) AP9801253A0 (cs)
AR (1) AR012244A1 (cs)
AU (1) AU7226798A (cs)
BG (1) BG103947A (cs)
BR (1) BR9810021A (cs)
CA (1) CA2293335A1 (cs)
CO (1) CO4940506A1 (cs)
CZ (1) CZ9904388A3 (cs)
EA (1) EA199901016A1 (cs)
GT (1) GT199800074A (cs)
HN (1) HN1998000073A (cs)
HR (1) HRP980316A2 (cs)
HU (1) HUP0002252A3 (cs)
ID (1) ID24529A (cs)
IL (1) IL132767A0 (cs)
IS (1) IS5251A (cs)
MA (1) MA26505A1 (cs)
NO (1) NO996108L (cs)
OA (1) OA11225A (cs)
PA (1) PA8451801A1 (cs)
PE (1) PE79899A1 (cs)
PL (1) PL337606A1 (cs)
TN (1) TNSN98083A1 (cs)
TR (1) TR199902995T2 (cs)
TW (1) TW448174B (cs)
WO (1) WO1998056800A1 (cs)
ZA (1) ZA985018B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
DE69926005T2 (de) * 1998-09-22 2006-05-18 Pfizer Products Inc., Groton Carbamat- und carbazatketolidantibiotika
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
NZ515027A (en) * 1999-04-16 2004-01-30 Kosan Biosciences Inc Erythromycin derivatives as antibiotics
OA11945A (en) 1999-05-24 2006-04-13 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
ES2208334T3 (es) * 1999-06-07 2004-06-16 Abbott Laboratories Derivados cetolida de 6-0 carbamato.
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
CA2529817C (en) * 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
WO2005085266A2 (en) 2004-02-27 2005-09-15 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
WO2009055557A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
WO2010048600A1 (en) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN108310000A (zh) 2009-09-10 2018-07-24 森普拉制药公司 治疗疟疾、结核病和mac疾病的方法
CN102146085B (zh) * 2010-02-09 2014-03-26 北京理工大学 一种9-肟醚酮内酯衍生物、制备方法及其药物组合物
CA2793884C (en) 2010-03-22 2019-09-10 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
US9051346B2 (en) 2010-05-20 2015-06-09 Cempra Pharmaceuticals, Inc. Process for preparing triazole-containing ketolide antibiotics
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
IN2014DN08939A (cs) 2012-03-27 2015-05-22 Cempra Pharmaceuticals Inc
RU2015138796A (ru) 2013-03-14 2017-04-19 Семпра Фармасьютикалс, Инк. Способы и составы для лечения респираторных заболеваний
WO2014145210A1 (en) 2013-03-15 2014-09-18 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
JP2000513026A (ja) 2000-10-03
HUP0002252A2 (hu) 2000-12-28
ZA985018B (en) 1999-12-10
BR9810021A (pt) 2000-09-19
TW448174B (en) 2001-08-01
TNSN98083A1 (fr) 2005-03-15
AR012244A1 (es) 2000-09-27
HUP0002252A3 (en) 2002-01-28
AP9801253A0 (en) 1999-12-04
PL337606A1 (en) 2000-08-28
KR20010013660A (ko) 2001-02-26
TR199902995T2 (xx) 2000-02-21
EP0988308A1 (en) 2000-03-29
GT199800074A (es) 1999-11-27
IS5251A (is) 1999-11-16
CO4940506A1 (es) 2000-07-24
ID24529A (id) 2000-07-20
HRP980316A2 (en) 1999-04-30
MA26505A1 (fr) 2004-12-20
NO996108L (no) 2000-02-10
CZ9904388A3 (cs) 2002-10-16
EA199901016A1 (ru) 2000-06-26
HN1998000073A (es) 1999-01-08
NO996108D0 (no) 1999-12-10
BG103947A (en) 2000-07-31
PA8451801A1 (es) 2000-05-24
AU7226798A (en) 1998-12-30
WO1998056800A1 (en) 1998-12-17
CA2293335A1 (en) 1998-12-17
CN1259135A (zh) 2000-07-05
OA11225A (en) 2003-07-17
IL132767A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
PE79899A1 (es) Derivados de la 9-oxima eritromicina
PE122499A1 (es) Derivados de 9-amino-3-ceto eritromicina
ATE217623T1 (de) Azindolethylaminderivate als nikotin-acetylcholin-rezeptor bindung verbindungen
RU97108157A (ru) Антимикробные фенилоксазолидиноны
SE9103572D0 (sv) Organic salts of n,n'-diacetyl cystine
PE46899A1 (es) Derivados de n-fenil-sulfonamida
FR2619111B1 (fr) Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
ES493922A0 (es) Procedimiento para la preparacion de 4-fenoxipiperidinas
NO924783L (no) Terapeutiske midler
DK0459256T3 (da) Oxazolidiononer
NZ503897A (en) 3,6-hemiketals from the class of 9a-azalides
DE69024778D1 (de) 2-Aminopyrimidin-4-carboxamid-Derivate, deren Herstellung und deren therapeutische Anwendung
SE8505887D0 (sv) Indoler
HUP9700595A1 (hu) Fluor-alkil- és fluor-alkoxicsoporttal helyettesített heterociklikus bradikinin-antagonisták, eljárás ezek előállítására, valamint ezek alkalmazása
PE122399A1 (es) Derivados de eritromicina triciclicos
FR2631625B1 (fr) Derives de phenyl-6 piperazinylalkyl-3 1h,3h-pyrimidinedione-2,4, leur preparation et leur application en therapeutique
ATE70274T1 (de) Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide.
KR880005927A (ko) 카복실산 아미드의 용도
DK47688D0 (da) 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thiadiaziner, deres fremstilling og anvendelse som laegemiddel
ES2059595T3 (es) Beta-carbonil-carboxiamidas de 1,3-tiazolidinas.
ES2008071A4 (es) Procedimiento de preparacion de compuestos policiclicos aromaticos.
NO991581L (no) N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler
DK0712411T3 (da) Antiparasitiske midler
ES555030A0 (es) Procedimiento para la obtencion de nuevos derivados de isoxazol
BG96664A (bg) Антихипертензивно средство

Legal Events

Date Code Title Description
FC Refusal